Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
QuintilesIMS
Boehringer Ingelheim
US Department of Justice
Covington
Daiichi Sankyo
Chubb
Mallinckrodt
Cipla

Generated: May 27, 2018

DrugPatentWatch Database Preview

Caspofungin acetate - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for caspofungin acetate and what is the scope of caspofungin acetate freedom to operate?

Caspofungin acetate
is the generic ingredient in two branded drugs marketed by Merck, Fresenius Kabi Usa, Gland Pharma Ltd, and Mylan Labs Ltd, and is included in four NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Caspofungin acetate has thirteen patent family members in thirteen countries.

There are eight drug master file entries for caspofungin acetate. Six suppliers are listed for this compound. There is one tentative approval for this compound.
Pharmacology for caspofungin acetate
Ingredient-typeLipopeptides
Drug ClassEchinocandin Antifungal
Synonyms for caspofungin acetate
(4R,5S)-5-((2-aminoethyl)amino)-N(2)-(10,12-dimethyltetradecanoyl)-4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline cyc
(4R,5S)-5-((2-Aminoethyl)amino)-N(sup 2)-(10,12-dimethyltetradecanoyl)-4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline
1-((4R,5S)-5-((2-Aminoethyl)amino)-N(sup 2)-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine)-5-((3R)-3-hydroxy-L-ornithine)pneumocandin B0, diacetate (salt)
1-[(4R,5S)-5-[(2-aminoethyl)amino]-N(2)-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine]-pneumocandin B0 diacetate
1-[(4R,5S)-5-[(2-Aminoethyl)amino]-N2-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine]-pneumocandin B0
1)-peptide diacetate salt
179463-17-3
463C173
AC-27763
AC1L3WZV
AKOS025401982
AKOS026750216
AM018463
AN-5345
AOB3093
C52H88N10O15.2C2H4O2
C56H96N10O19
Cancidas
Caspofungin (Acetate)
Caspofungin acetate (JAN/USAN)
Caspofungin acetate [USAN:BAN:JAN]
Caspofungin Acetate [USAN]
caspofungin diacetate
CHEBI:59900
CS-0578
D02501
FT-0664404
HY-17006
J-011452
L 743,872
L 743872
L-743872
LS-173700
MK 0991
MK0991
MolPort-029-887-122
MolPort-035-395-717
MolPort-044-561-291
N-[3-(3-AMINO-1-HYDROXYPROPYL)-21-[(2-AMINOETHYL)AMINO]-6-[1,2-DIHYDROXY-2-(4-HYDROXYPHENYL)ETHYL]-11,20,25-TRIHYDROXY-15-(1-HYDROXYETHYL)-2,5,8,14,17,23-HEXAOXO-1,4,7,13,16,22-HEXAAZATRICYCLO[22.3.0.0?,(1)(3)]HEPTACOSAN-18-Y
N-{(2R,6S,9S,11R,12S,14aS,15S,20S,23S,25aS)-12-[(2-aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11,15-trihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,22,25-hexaoxotetra
OGUJBRYAAJYXQP-LLXMLGLCSA-N
Pneumocandin B0, 1-((4R,5S)-5-((2-aminoethyl)amino)-N2-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine)-5-((3R)-3-hydroxy-L-ornithine)-, diacetate (salt)
s3073
SCHEMBL149293
UNII-VUW370O5QE
VUW370O5QE
W-5367
Y1176
Tentative approvals for CASPOFUNGIN ACETATE
Applicant Application No. Strength Dosage Form
➤ Try a Free Trial➤ Try a Free Trial50MG/VIALINJECTABLE; INJECTION
➤ Try a Free Trial➤ Try a Free Trial70MG/VIALINJECTABLE; INJECTION

US Patents and Regulatory Information for caspofungin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa CASPOFUNGIN ACETATE caspofungin acetate POWDER;IV (INFUSION) 206110-001 Dec 30, 2016 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Mylan Labs Ltd CASPOFUNGIN ACETATE caspofungin acetate POWDER;IV (INFUSION) 207650-001 Sep 29, 2017 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Merck CANCIDAS caspofungin acetate POWDER;IV (INFUSION) 021227-002 Jan 26, 2001 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Labs Ltd CASPOFUNGIN ACETATE caspofungin acetate POWDER;IV (INFUSION) 207650-002 Sep 29, 2017 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for caspofungin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck CANCIDAS caspofungin acetate POWDER;IV (INFUSION) 021227-002 Jan 26, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Merck CANCIDAS caspofungin acetate POWDER;IV (INFUSION) 021227-001 Jan 26, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Merck CANCIDAS caspofungin acetate POWDER;IV (INFUSION) 021227-001 Jan 26, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Merck CANCIDAS caspofungin acetate POWDER;IV (INFUSION) 021227-002 Jan 26, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Supplementary Protection Certificates for caspofungin acetate

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
/2001 Austria ➤ Try a Free Trial PRODUCT NAME: CASPOFUNGIN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, INSBESONDERE CASPOFUNGINACETAT; REGISTRATION NO/DATE: EU/01/196/001-003 20011024
00076 Netherlands ➤ Try a Free Trial PRODUCT NAME: CASPOFUNGINE, DESGEWENST IN DE VORM VAN EEN ZUURADDITIEZOUT, IN HET BIJZONDER CASPOFUNGINE ACETAAT; REGISTRATION NO/DATE: EU/1/01/196/001-003 20011024
C0054 France ➤ Try a Free Trial PRODUCT NAME: CASPOFUNGIN ACETATE; REGISTRATION NO/DATE: EU/1/01/196/001 20011024
01/029 Ireland ➤ Try a Free Trial PRODUCT NAME: CASPOFUNGIN, OPTIONALLY IN THE FORM OF PHARMACEUTICALLY ACCEPTABLE SALT, ESPECIALLY CASPOFUNGIN ACETATE; REGISTRATION NO/DATE: EU/1/01/196/001-003 20011024; PAEDIATRIC INV. PLAN: P/30/2008
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Queensland Health
Johnson and Johnson
AstraZeneca
US Department of Justice
Argus Health
QuintilesIMS
Covington
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.